ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,943Medicare Part D Prescriptions Filled, Including Refills

Rank: 573 out of 3593

$464K Total Retail Price of All Prescriptions

Rank: 727 out of 3593

470 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 470 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 470 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,119 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE-BENAZEPRIL 641 592 10 1 65
PRAVASTATIN SODIUM 483 448 2 13
SIMVASTATIN 366 341 3 1
LEVOTHYROXINE SODIUM 352 321 4 4
METFORMIN HCL ER 304 279 5 67
LOSARTAN POTASSIUM 286 259 6 14
RANITIDINE HCL 253 221 7 27
AMLODIPINE BESYLATE 251 223 8 3
PANTOPRAZOLE SODIUM 237 219 9 45
EXFORGE 217 207 10 214
OMEPRAZOLE 187 159 11 5
METOPROLOL SUCCINATE 162 138 12 19
LISINOPRIL 161 159 13 2
ATORVASTATIN CALCIUM 156 143 14 15
WARFARIN SODIUM 145 128 15 18
METOPROLOL TARTRATE 142 141 16 8
FUROSEMIDE 136 136 17 9
ALLOPURINOL 135 127 18 35
NEXIUM 133 120 19 36
FELODIPINE ER 128 127 20 229
GLIMEPIRIDE 117 107 21 44
METFORMIN HCL 112 105 22 6
IRBESARTAN 103 91 23 258
SERTRALINE HCL 103 92 23 28
HYDROCHLOROTHIAZIDE 100 97 25 10
TRAMADOL HCL 93 90 26 17
ATENOLOL 91 91 27 11
FENOFIBRATE 83 69 28 39
ESTRADIOL 81 62 R 29 174
BISOPROLOL-HYDROCHLOROTHIAZIDE 79 70 30 201
TRIAMCINOLONE ACETONIDE 78 69 31 119
NIFEDIPINE ER 77 68 32 75
CLOPIDOGREL 77 77 32 30
PREDNISONE 76 69 34 49
HYDROCODONE-ACETAMINOPHEN 71 62 S3 35 7
ZOLPIDEM TARTRATE 71 62 35 12
GABAPENTIN 67 58 37 16
AZITHROMYCIN 66 58 38 34
ACETAMINOPHEN-CODEINE 66 62 S3 38 153
LOVASTATIN 64 53 40 20
TAMSULOSIN HCL 62 60 41 33
DIGOXIN 56 56 42 58
AMITRIPTYLINE HCL 55 45 R 43 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 53 43 26
CELEBREX 54 51 45 100
CARVEDILOL 52 51 46 23
TRIBENZOR 51 51 47 416
FINASTERIDE 50 48 48 79
NAPROXEN 50 41 48 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.